Join us in this episode for a conversation with Argyrios “Argy” Stampas, MD, physiatrist, Vice Chair of Research and Innovation and Full Professor in the Department of Physical Medicine and Rehabilitation at UTHealth Houston’s McGovern Medical School, and Director of Spinal Cord Injury Medicine Research at TIRR Memorial Hermann. In this conversation we discuss the paper titled “Reduction of Overactive Bladder Medications in Spinal Cord Injury with Self-Administered Neuromodulation: A randomized Trial" published in The Journal of Urology. In this paper Dr. Stampas discusses self-administered tibial nerve stimulation (TNS) for neurogenic bladder after spinal cord injury (SCI). The discussion highlights how noninvasive neuromodulation can reduce overactive bladder medication use, explores the underlying mechanisms, and considers what these findings mean for daily life and future SCI bladder management. We invite you to listen in as Dr. Stampas describes this device with the potential to reduce drug dependence for overactive bladder, and trust you will enjoy this episode.

Join us in this episode for a conversation with Argyrios “Argy” Stampas, MD, physiatrist, Vice Chair of Research and Innovation and Full Professor in the Department of Physical Medicine and Rehabilitation at UTHealth Houston’s McGovern Medical School, and Director of Spinal Cord Injury Medicine Research at TIRR Memorial Hermann. In this conversation we discuss the paper titled “Reduction of Overactive Bladder Medications in Spinal Cord Injury with Self-Administered Neuromodulation: A randomized Trial" published in The Journal of Urology. In this paper Dr. Stampas discusses self-administered tibial nerve stimulation (TNS) for neurogenic bladder after spinal cord injury (SCI). The discussion highlights how noninvasive neuromodulation can reduce overactive bladder medication use, explores the underlying mechanisms, and considers what these findings mean for daily life and future SCI bladder management. We invite you to listen in as Dr. Stampas describes this device with the potential to reduce drug dependence for overactive bladder, and trust you will enjoy this episode.

Join us this episode for a conversation with Linda Ehrlich-Jones, RN, PhD, Associate Director of the Center for Rehabilitation Outcomes Research at Shirley Ryan AbilityLab and a Research Professor in the Department of Physical Medicine & Rehabilitation at Northwestern University Feinberg School of Medicine. In this conversation we discuss the current state of the art in medicine for chronic pain in people living with spinal cord injury (SCI), with a focus on care that does not require drugs. The paper explaining the process is titled "Behavioral/Physical and Stimulation Interventions for Chronic Pain Following Spinal Cord Injury: A systematic review" published in Topics in Spinal Cord Injury Rehabilitation. In this paper Dr. Ehrlich-Jones compared behavioral and complementary therapies with neuromodulation-based stimulation approaches for managing chronic neuropathic (or "nerve") pain after SCI. We invite you to listen in as Dr. Ehrlich-Jones gives a thorough current update on drug-free pain management, and trust you will enjoy this episode.

Join us this episode for a conversation with Linda Ehrlich-Jones, RN, PhD, Associate Director of the Center for Rehabilitation Outcomes Research at Shirley Ryan AbilityLab and a Research Professor in the Department of Physical Medicine & Rehabilitation at Northwestern University Feinberg School of Medicine. In this conversation we discuss the current state of the medical evidence for intervening on chronic pain in people living with spinal cord injury, with a focus on strategies that do not require drugs. The paper explaining the process is titled "Behavioral/Physical and Stimulation Interventions for Chronic Pain Following Spinal Cord Injury: A systematic review" published in Topics in Spinal Cord Injury Rehabilitation. In this paper Dr. Ehrlich-Jones discuss a systematic literature review that compared behavioral and complementary therapies with neuromodulation-based stimulation approaches for managing chronic neuropathic pain after SCI, including their evidence base, clinical feasibility, and implications for future treatment innovation. We invite you to listen in as Dr. Ehrlich-Jones gives a thorough current update on non-pharmacological pain management, and trust you will enjoy this episode.

The National Spinal Cord Injury Statistical Center (NSCISC) coalesces data from the Spinal Cord Injury Model Systems Centers (SCIMS), a network of combined research and care teams that specialize in spinal cord injury (SCI). The statistical center generates national SCI demography, published in their annual full report and "facts and figures" summary. In this summary, a variety of experts will tell us about their use of the NSCISC and their experience with SCIMS, including a history of these important national services and the importance of continuing them into the future.

Importantly, this episode was planned and hosted in conjunction with INside the OUTcomes: A Rehabilitation Research Podcast, with their producer-host Sharon Parmet.

Join us this episode for a conversation with Stephen Burns, MD, physiatrist, Professor of PM&R at University of Washington School of Medicine in Seattle, and Director of SCI Service at VA Puget Sound. In this conversation we discuss the process of shortening, or expediting, the International Standards for the Neurological Classification of Spinal Cord Injury (ISNCSCI) exam. Most people know this exam, which assigns a level and grade to their injury, as their "ASIA" exam. The paper explaining the process is titled "“Development and validation of an algorithm for item reduction of the International Standards for Neurological Classification of Spinal Cord Injury examination to determine level and severity of SCI" which was recently accepted for publication in Topics in Spinal Cord Injury Rehabilitation." In this paper Dr. Burns and their team discuss the process by which this rather long exam can be reduced to less than half the items with acceptable accuracy for some, but not all, types of spinal cord injury. We invite you to listen in as Dr. Burns gives an insider perspective on the new E-ISNCSCI, and trust you will enjoy this episode on making an important but long exam quite a bit shorter.

Other resources:

• ASIA's webpage on the E-ISNCSCI: https://asia-spinalinjury.org/expedited-isncsci-exam/
• Upcoming webinar on the E-ISNCSCI: https://asia-spinalinjury.org/tscir-webinars/

Join us this episode for a conversation with Stephen Burns, MD, physiatrist, Professor of PM&R at University of Washington School of Medicine in Seattle, and Director of SCI Service at VA Puget Sound. In this conversation we discuss the process of minting a shortened, or expedited, version of the International Standards for the Neurological Classification of Spinal Cord Injury (ISNCSCI) exam. The paper explaining the process is titled "“Development and validation of an algorithm for item reduction of the International Standards for Neurological Classification of Spinal Cord Injury examination to determine level and severity of SCI" which was recently accepted for publication in Topics in Spinal Cord Injury Rehabilitation." In this paper Dr. Burns and their team discuss the process by which a 134 item physical exam can be reduced to 42 +/- 10 exam items with acceptable accuracy for some, but not all, neurological levels and impairment scales. We invite you to listen in as Dr. Burns gives an insider perspective on the E-ISNCSCI-V2, and trust you will enjoy this episode on the second iteration of shorting the ISNCSCI.

Other resources:

• ASIA's webpage on the E-ISNCSCI: https://asia-spinalinjury.org/expedited-isncsci-exam/
• Upcoming webinar on the E-ISNCSCI: https://asia-spinalinjury.org/tscir-webinars/

Join us this episode for a conversation with Norbert Weidner, MD, Professor and Chair of the Spinal Cord Injury Center at Heidelberg University Hospital. In this conversation we discuss results of a clinical trial called the Neuroimmunophilin Nogo-A Antibody in Spinal Cord Injury (NISCI) trial. Findings from this trial were published in a paper titled "Safety and efficacy of intrathecal antibodies to Nogo-A in patients with acute cervical spinal cord injury: a randomised, double-blind, multicentre, placebo-controlled, phase 2b trial" in the journal Lancet Neurology. In this paper Weidner and the NISCI team discuss the top-line findings from this large multi-center clinical trial where a drug (with antibodies against Nogo-A, a protein found in the walls of spinal cord neurons and their support cells) were given to people early after their accident. We invite you to listen in as Dr. Weidner gives an insider perspective on the NISCI trial, and trust you will enjoy our conversation on new pharmaology in the acute phase of SCI.